前往化源商城

5,6,7,8-四羟基-2-萘甲酸

更新时间:2025-08-25 09:57:02

5,6,7,8-四羟基-2-萘甲酸结构式
5,6,7,8-四羟基-2-萘甲酸结构式
品牌特惠专场
常用名 5,6,7,8-四羟基-2-萘甲酸 英文名 5,6,7,8-Tetrahydro-2-naphthalenecarboxylic acid
CAS号 1131-63-1 分子量 176.212
密度 1.2±0.1 g/cm3 沸点 332.4±31.0 °C at 760 mmHg
分子式 C11H12O2 熔点 152-156 °C
MSDS 中文版 美版 闪点 152.5±19.5 °C
符号 GHS07
GHS07
信号词 Warning

 5,6,7,8-四羟基-2-萘甲酸名称

中文名 5,6,7,8-四羟基-2-萘甲酸
英文名 5,6,7,8-tetrahydro-2-naphthoic acid
中文别名 5,6,7,8-四氢-2-萘甲酸
英文别名 更多

 5,6,7,8-四羟基-2-萘甲酸物理化学性质

密度 1.2±0.1 g/cm3
沸点 332.4±31.0 °C at 760 mmHg
熔点 152-156 °C
分子式 C11H12O2
分子量 176.212
闪点 152.5±19.5 °C
精确质量 176.083725
PSA 37.30000
LogP 3.58
InChIKey RSWXAGBBPCRION-UHFFFAOYSA-N
SMILES O=C(O)c1ccc2c(c1)CCCC2
蒸汽压 0.0±0.8 mmHg at 25°C
折射率 1.586
储存条件 室温
分子结构

1、 摩尔折射率:49.96

2、 摩尔体积(cm3/mol):148.7

3、 等张比容(90.2K):395.6

4、 表面张力(dyne/cm):49.9

5、 极化率(10-24cm3):19.80

计算化学

1.疏水参数计算参考值(XlogP):2.8

2.氢键供体数量:1

3.氢键受体数量:2

4.可旋转化学键数量:1

5.互变异构体数量:3

6.拓扑分子极性表面积37.3

7.重原子数量:13

8.表面电荷:0

9.复杂度:200

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

更多

1.密度(g/cm3):1.184

2.熔点(ºC):152-156

3.沸点(760 mmHg,ºC):332.4

4.闪点(ºC):152.5

 5,6,7,8-四羟基-2-萘甲酸安全信息

符号 GHS07
GHS07
信号词 Warning
危害声明 H302
危害码 (欧洲) Xi: Irritant;Xn: Harmful;
风险声明 (欧洲) R22
危险品运输编码 NONH for all modes of transport
海关编码 2916399090

 5,6,7,8-四羟基-2-萘甲酸合成线路

 5,6,7,8-四羟基-2-萘甲酸海关

海关编码 2916399090
中文概述 2916399090 其他芳香一元羧酸. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%
申报要素 品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装
Summary 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

 5,6,7,8-四羟基-2-萘甲酸靶点实验

查看更多实验

实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
实验名称:A screen for small molecules that modulate mitochondrial supercomplex formation
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1482
实验名称:Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:ORF 73 [Human herpesvirus 8 type M]
External Id:HMS791
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
实验名称:Stabilization of p53 in human papillomavirus-positive cells
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Cellular tumor antigen p53
External Id:HMS1485
实验名称:Discovering small molecule activators of G protein-gated inwardly-rectifying potassiu...
来源:15621
靶标:G protein-activated inward rectifier potassium channel 2
External Id:VANDERBILT_HTS_GIRK2_MPD
实验名称:A screen for compounds that inhibit viral RNA polymerase binding and polymerization a...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Chain A, Poliovirus Polymerase With Gtp
External Id:HMS750
共10条,当前第1页,共1页
1

 5,6,7,8-四羟基-2-萘甲酸英文别名

5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
MFCD01861899
EINECS 214-469-6
5,6,7,8-Tetrahydro-2-naphthalenecarboxylic acid
5,6,7,8-Tetrahydro-naphthalene-2-carboxylic acid
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。